(Q53946077)

English

Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin. (English)

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

0 references

atherosclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Brown AS

1

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

Bakker-Arkema RG

2

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

Yellen L

3

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

Henley RW Jr

4

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

Guthrie R

5

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

Campbell CF

6

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

Koren M

7

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

Woo W

8

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

McLain R

9

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

Black DM

10

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

language of work or name

0 references

publication date

1 September 1998

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

Journal of the American College of Cardiology

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

32

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

665-672

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

3

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

Prevention and regression of coronary atherosclerosis. Is it safe and efficacious therapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900300-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900300-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900300-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900300-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900300-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of one-year efficacy and safety of atorvastatin versus lovastatin in primary hypercholesterolemia. Atorvastatin Study Group I.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900300-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900300-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug therapy for hypercholesterolemia in patients with cardiovascular disease: factors limiting achievement of lipid goals

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2898%2900300-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0735-1097(98)00300-3

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

1 reference

Europe PubMed Central

22 May 2018

http://europepmc.org/abstract/MED/9741509

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53946077&oldid=1408841838"